AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mivorab D 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Avion Healthcare Pvt Ltd

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Mivorab D 30mg/20mg Capsule SR

Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with the combined medication Mivorab D 30mg/20mg SR Capsules. This formulation alleviates symptoms like heartburn, stomach upset, and irritation by neutralizing stomach acid and facilitating gas expulsion for improved comfort. As directed by your physician, take Mivorab D 30mg/20mg SR Capsules on an empty stomach, following the prescribed dosage and duration. Treatment length depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and condition worsening. Always inform your healthcare provider of all other medications you are using, as interactions are possible. Common, usually transient, side effects include diarrhea, abdominal pain, dry mouth, headache, gas, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness may occur; refrain from driving or tasks requiring alertness until effects are known. Alcohol consumption should be avoided due to potential drowsiness exacerbation. Dietary changes, such as consuming cold milk and avoiding caffeine, spicy foods, and chocolate, can complement treatment. Prior to commencing treatment, disclose any kidney or liver conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor.

Uses of Mivorab D 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Mivorab D 30mg/20mg Capsule SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Mivorab D 30mg/20mg Capsule SR whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Mivorab D 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Mivorab D 30mg/20mg Capsule SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Administer Mivorab D 30mg/20mg Sustained-Release Capsule on an empty stomach.

How Mivorab D 30mg/20mg Capsule SR works:

Mivorab D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole, two medications working synergistically. Domperidone, a prokinetic agent, enhances gastrointestinal motility, facilitating smoother food passage. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from heartburn and acid indigestion.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Mivorab D 30mg/20mg SR capsules with alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Mivorab D 30mg/20mg capsules may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Using Mivorab D 30mg/20mg SR capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Mivorab D 30mg/20mg sustained-release capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Exercise caution when administering Mivorab D 30mg/20mg sustained-release capsules to individuals with impaired renal function. Dosage modification of Mivorab D 30mg/20mg sustained-release capsules might be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Mivorab D 30mg/20mg sustained-release capsules cautiously, potentially requiring dosage modification. Physician consultation is advised. Mivorab D 30mg/20mg sustained-release capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.

What if you forget to take Mivorab D 30mg/20mg Capsule SR :

Should you forget to take a Mivorab D 30mg/20mg Capsule SR, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mivorab D 30mg/20mg Capsule SR

LabelValue
Potential for Dependence None.
Medication Category Gastrointestinal tract

FAQs on Mivorab D 30mg/20mg Capsule SR

Mivorab D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual medication treats heartburn, acid reflux (GERD—gastroesophageal reflux disease), where stomach acid rises into the esophagus, and also gastric and duodenal ulcers. Domperidone's action on gut motility facilitates improved food passage through the stomach, thus managing nausea and vomiting.
Mivorab D 30mg/20mg SR capsules are contraindicated in individuals with documented hypersensitivity to rabeprazole, domperidone, or any formulation excipients. Patients with pre-existing hepatic or renal impairment require careful monitoring during treatment.
Indeed, taking Mivorab D 30mg/20mg SR capsules may lead to xerostomia (dry mouth). This side effect is attributed to the Domperidone component. To alleviate dry mouth, increase your fluid intake. Keep a water source readily available overnight. Reducing alcohol consumption and abstaining from smoking are also advisable. For dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Mivorab D 30mg/20mg sustained-release capsules. If diarrhea occurs, increase fluid intake. Restrict consumption of greasy or deep-fried foods while taking this medication. Consult your physician if diarrhea continues or if you observe dehydration symptoms such as reduced urination and dark, concentrated urine.
Maintain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent access by children, pets, and others.
Mivorab D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience side effects such as diarrhea, abdominal pain, gas, dry mouth, vertigo, or headache; less frequent or rare adverse reactions are also possible. Report any ongoing issues to your physician during treatment.
Optimal absorption of Mivorab D 30mg/20mg sustained-release capsules is achieved when administered prior to the initial meal or while fasting.
Taking Mivorab D 30mg/20mg Capsule SR may raise the likelihood of an irregular heart rhythm (serious arrhythmias). While this is a significant potential side effect, the probability is quite small. However, the risk might be marginally elevated for individuals over 60.
Mivorab D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This formulation manages heartburn, acid reflux (GERD), and ulcers affecting the stomach and duodenum. GERD involves stomach acid rising into the esophagus. Domperidone's action on gut motility facilitates easier food passage through the stomach, thus mitigating nausea and vomiting.
Mivorab D 30mg/20mg sustained-release capsules are contraindicated in individuals with documented hypersensitivity to rabeprazole, domperidone, or any excipient within the formulation. Patients with pre-existing hepatic or renal impairment require careful monitoring when using this medication.
Indeed, Mivorab D 30mg/20mg SR capsules may induce xerostomia (dry mouth), a side effect attributed to the domperidone component. To alleviate this, increase your fluid intake; keeping water readily available, especially overnight, is advisable. Reducing alcohol consumption and abstaining from smoking are also recommended. For dry mouth, opt for alcohol-free mouthwash to minimize the potential for dental caries.
Diarrhea is a potential side effect of Mivorab D 30mg/20mg SR Capsules. If diarrhea occurs, increase fluid intake. Avoid high-fat foods while taking this medication. Consult your physician if diarrhea continues or if dehydration symptoms, such as decreased urination and dark, concentrated urine, appear.
Mivorab D 30mg/20mg SR capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse effects such as diarrhea, abdominal pain, flatulence, dry mouth, vertigo, and headache; less frequent or rare reactions are also possible. Report any ongoing issues to your physician during treatment.
Optimal absorption of Mivorab D 30mg/20mg sustained-release capsules is achieved by ingestion prior to the initial meal or while fasting.
Taking Mivorab D 30mg/20mg SR Capsules may raise the likelihood of an abnormal heart rhythm (serious arrhythmias). While this is a significant potential adverse reaction, the probability is quite small. However, the risk might be marginally elevated for individuals over sixty.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines printed on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Mivorab D 30mg/20mg Capsu...
72
MRP 88
18% off